<DOC>
	<DOCNO>NCT00292721</DOCNO>
	<brief_summary>Several study include report celecoxib improves endothelium-dependent vasodilation reduces inflammation neointimal hyperplasia . Our hypothesis celecoxib may reduce late luminal loss coronary stent implantation ( paclitaxel-eluting stent .</brief_summary>
	<brief_title>Effects Celecoxib After Percutaneous Coronary Intervention</brief_title>
	<detailed_description />
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Coronary artery disease least 1 de novo lesion great 50 % stenosis coronary angiography Acute ST elevation MI Left main disease Contraindications aspirin , clopidogrel celecoxib Severe congestive heart failure Expected survival &lt; 2 year Hepatic dysfunction Currently take NSAIDs COX2 inhibitor Renal dysfunction Use warfarin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>